Works matching IS 00145793 AND DT 2014 AND VI 588 AND IP 2

Results: 23

Glypican-3 antibodies: A new therapeutic target for liver cancer.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 377, doi. 10.1016/j.febslet.2013.10.002

By:

Feng, Mingqian;
Ho, Mitchell

Publication type:

Article

Checkpoint blocking antibodies in cancer immunotherapy.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 368, doi. 10.1016/j.febslet.2013.10.015

By:

Kyi, Chrisann;
Postow, Michael A.

Publication type:

Article

Development of inhibitors in the ubiquitination cascade.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 356, doi. 10.1016/j.febslet.2013.11.003

By:

Zhang, Wei;
Sidhu, Sachdev S.

Publication type:

Article

Tapping the treasure of intracellular oncotargets with immunotherapy.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 350, doi. 10.1016/j.febslet.2013.10.025

By:

Hong, Cheng William;
Zeng, Qi

Publication type:

Article

Phage protein-targeted cancer nanomedicines.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 341, doi. 10.1016/j.febslet.2013.11.011

By:

Petrenko, V.A.;
Jayanna, P.K.

Publication type:

Article

Protein engineering to target complement evasion in cancer.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 334, doi. 10.1016/j.febslet.2013.11.007

By:

Carter, Darrick;
Lieber, André

Publication type:

Article

A computational tool to predict the evolutionarily conserved protein–protein interaction hot-spot residues from the structure of the unbound protein.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 326, doi. 10.1016/j.febslet.2013.11.004

By:

Agrawal, Neeraj J.;
Helk, Bernhard;
Trout, Bernhardt L.

Publication type:

Article

Profiling the IgOme: Meeting the challenge.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 318, doi. 10.1016/j.febslet.2013.11.005

By:

Weiss-Ottolenghi, Yael;
Gershoni, Jonathan M.

Publication type:

Article

Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 308, doi. 10.1016/j.febslet.2013.11.027

By:

Zhang, Hao;
Cui, Weidong;
Gross, Michael L.

Publication type:

Article

Protein engineering strategies for the development of viral vaccines and immunotherapeutics.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 298, doi. 10.1016/j.febslet.2013.10.014

By:

Koellhoffer, Jayne F.;
Higgins, Chelsea D.;
Lai, Jonathan R.

Publication type:

Article

Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 288, doi. 10.1016/j.febslet.2013.11.030

By:

Ahmed, Mahiuddin;
Cheung, Nai-Kong V.

Publication type:

Article

Therapeutic antibody engineering by high efficiency cell screening.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 278, doi. 10.1016/j.febslet.2013.11.025

By:

Doerner, Achim;
Rhiel, Laura;
Zielonka, Stefan;
Kolmar, Harald

Publication type:

Article

Stability engineering of the human antibody repertoire.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 269, doi. 10.1016/j.febslet.2013.11.029

By:

Rouet, Romain;
Lowe, David;
Christ, Daniel

Publication type:

Article

Engine out of the chassis: Cell-free protein synthesis and its uses.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 261, doi. 10.1016/j.febslet.2013.10.016

By:

Rosenblum, Gabriel;
Cooperman, Barry S.

Publication type:

Article

Recent advances in mammalian protein production.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 253, doi. 10.1016/j.febslet.2013.11.035

By:

Bandaranayake, Ashok D.;
Almo, Steven C.

Publication type:

Article

Targeted expression, purification, and cleavage of fusion proteins from inclusion bodies in Escherichia coli.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 247, doi. 10.1016/j.febslet.2013.09.028

By:

Hwang, Peter M.;
Pan, Jonathan S.;
Sykes, Brian D.

Publication type:

Article

Production of prone-to-aggregate proteins.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 236, doi. 10.1016/j.febslet.2013.10.044

By:

Lebendiker, Mario;
Danieli, Tsafi

Publication type:

Article

Mutations of Asp540 and the domain-connecting residues synergistically enhance Pyrococcus furiosus DNA ligase activity.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 230, doi. 10.1016/j.febslet.2013.10.037

By:

Tanabe, Maiko;
Ishino, Sonoko;
Ishino, Yoshizumi;
Nishida, Hirokazu

Publication type:

Article

Directed polymerase evolution.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 219, doi. 10.1016/j.febslet.2013.10.040

By:

Chen, Tingjian;
Romesberg, Floyd E.

Publication type:

Article

Anticalins: Exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 213, doi. 10.1016/j.febslet.2013.11.006

By:

Richter, A.;
Eggenstein, E.;
Skerra, A.

Publication type:

Article

Protein disulfide engineering.

Published in:

FEBS Letters, 2014, v. 588, n. 2, p. 206, doi. 10.1016/j.febslet.2013.11.024

By:

Dombkowski, Alan A.;
Sultana, Kazi Zakia;
Craig, Douglas B.

Publication type:

Article

Protein Engineering.

Published in:

2014

By:

Just, Wilhelm

Publication type:

Editorial

Editorial Board.

Published in:: FEBS Letters, 2014, v. 588, n. 2, p. i, doi. 10.1016/S0014-5793(13)00902-2
Publication type:: Article